Traditional Chinese and Western Medicine for Knee Osteoarthritis
TCMWMKOA
Investigation of Traditional Chinese and Western Medicine in the Real World of Knee Osteoarthritis: A Multicenter Cohort Study
1 other identifier
observational
5,000
1 country
1
Brief Summary
A cohort study will be used to collect patient data, analyze the clinical characteristics, traditional Chinese medicine (TCM) syndromes, and treatment of knee osteoarthritis (KOA) in China to accumulate clinical data and clarify the status of KOA in the real world background. It will lay a clinical foundation for further study of KOA in the future, and bring certain clinical value for Chinese patients with KOA.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 12, 2021
CompletedStudy Start
First participant enrolled
October 1, 2021
CompletedFirst Posted
Study publicly available on registry
November 24, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedNovember 24, 2021
November 1, 2021
3 years
August 12, 2021
November 13, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Patient-assessed Pain (rest pain) Visual Analog Scale (VAS) score
The pain VAS is a continuous scale comprised of a horizontal (HVAS) or vertical (VVAS) line, 10 centimeters (100 mm) in length, each end of this scale is an extreme label of the symptom, "no pain" (corresponding to the scale of 0) and "pain too intense to be tolerated" (corresponding to the scale of 100). Respondents indicate their degree of acceptance to a statement by specifying a point on the continuous scale in between two endpoints. Using a ruler, the score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity.
1 month
The Knee Injury and Osteoarthritis Outcome Score (KOOS)
KOOS is a self-administered, knee-specific instrument to assess the patients' opinion about their knee and associated problems. The KOOS evaluates both short-term and long-term consequences of knee injury. It holds 42 items in 5 separately scored subscales: * Symptoms \& Stiffness (7 items) * Pain (9 items) * Function in daily living (ADL Function) (17 items) * Sport and Recreation Function (5 items) * Quality of Life (4 items) A Likert scale is used and all items have 5 possible answer options scored from 0 (No Problems) to 4 (Extreme Problems) and each of the 5 scores is calculated as the sum of the items included. Scores are transformed to a 0-100 scale, with zero representing extreme knee problems and 100 representing no knee problems as common in orthopedic assessment scales and generic measures. Scores between 0 and 100 represent the percentage of total possible score achieved.
1 month
WOMAC Knee Osteoarthritis Index Score
WOMAC knee osteoarthritis index is a self-administered questionnaire consisting of 24 items divided into 3 subscales: * Pain (5 items): * Stiffness (2 items): * Physical Function (17 items) A Likert scale is used and all items have 5 possible answer options: none (0), mild (1), moderate (2), severe (3), and extreme (4). A total WOMAC score is created by summing the items for all three subscales (0-96), and higher scores indicate worse pain, stiffness, and functional limitations.
1 month
TCM Syndrome Differentiation and Symptom Score
Patients' health as characterized by CM diagnostic pattern \& clinical characteristics is recorded using the standard of TCM syndrome differentiation that adopts the 2019 Chinese Society of Chinese Medicine Clinical Diagnosis and Treatment Guidelines for TCM Orthopedics and Traumatology - Knee Arthritis (Knee Osteoarthritis) Syndrome Differentiation Standard (cold-damp arthralgia syndrome, damp-heat arthralgia syndrome, stagnation of Qi and blood stasis syndrome, liver and kidney deficiency syndrome, and qi and blood weakness syndrome)
1 month
Secondary Outcomes (11)
Knee Joint Function
1 month
Morning Stiffness Time (in minutes)
1 month
9-Item Patient Health Questionnaire (PHQ-9),
1 month
12-Item Short Form Survey (SF-12) for Quality of Life of Patients
1 month
Complete blood count (CBC)
1 month
- +6 more secondary outcomes
Interventions
A cohort study will be used to collect patient data, analyze the clinical characteristics, TCM syndromes, and treatment of knee osteoarthritis in China
Eligibility Criteria
5000 patients who meet the diagnostic criteria for knee osteoarthritis from the 23 affiliated hospitals/centers across China will be recruited
You may qualify if:
- The patient has repeated knee joint pain in the past month;
- X-ray film (standing position or weight-bearing position) shows narrowing of the joint space, subchondral bone sclerosis and/or cystic degeneration, and osteophyte formation on the joint edges;
- Age ≥50 years old;
- Morning stiffness time ≤30min;
- There is bone friction sound (sensation) during activity.
- Patients who meet the diagnostic criteria 1 + (any 2 of 2, 3, 4, 5) can be diagnosed as KOA.
You may not qualify if:
- Patients who do not meet the diagnostic criteria for knee osteoarthritis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hong Kong Baptist Universitylead
- Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicinecollaborator
- Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of TCMcollaborator
- China-Japan Friendship Hospitalcollaborator
- First Affiliated Hospital of Harbin Medical Universitycollaborator
- Henan Provincial People's Hospitalcollaborator
- Jiangsu Province Hospital of Traditional Chinese Medicinecollaborator
- The First Affiliated Hospital with Nanjing Medical Universitycollaborator
- Affiliated Hospital of Nanjing University of Chinese Medicinecollaborator
- Traditional Chinese Medicine Hospital of Xinjiang Uygur Autonomous Regioncollaborator
- First Affiliated Hospital of Heilongjiang Chinese Medicine Universitycollaborator
- Integrated Hospital of Traditional Chinese Medicine, Southern Medical Universitycollaborator
- Ruijin Hospitalcollaborator
- The Second Clinical Medical College of Zhejiang University of Traditional Chinese Medicinecollaborator
- Affiliated Hospital of Shandong University of Traditional Chinese Medicinecollaborator
- Southwest Hospital, Chinacollaborator
- The Second People's Hospital Affiliated to Fujian University of Traditional Chinese Medicinecollaborator
- The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicinecollaborator
- ShuGuang Hospitalcollaborator
- Shanghai Municipal Hospital of Traditional Chinese Medicine Affiliated to Shanghai University of TCMcollaborator
- Shanghai University of Traditional Chinese Medicinecollaborator
- Dongzhimen Hospital, Beijingcollaborator
- Nanfang Hospital, Southern Medical Universitycollaborator
- The First Affiliated Hospital of Nanchang Universitycollaborator
Study Sites (1)
Hong Kong
Kowloon Tong, Kowloon, Hong Kong
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Linda Zhong, MD, PhD
Hong Kong Baptist University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Month
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
August 12, 2021
First Posted
November 24, 2021
Study Start
October 1, 2021
Primary Completion
October 1, 2024
Study Completion
December 1, 2024
Last Updated
November 24, 2021
Record last verified: 2021-11